NCT07445087

A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

A Post Marketing Surveillance Study (Usage Results Study) for Takhzyro in South Korea

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 35 (estimated)
• Sponsor: Takeda · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care. The treatment of participants and any check-ups will be determined by the treating doctors according to their normal practice. Participants may visit the study clinic several times during the study.

Conditions

• Hereditary Angioedema (HAE)

Interventions

Type	Name	Description
OTHER	No intervention	This is a non-interventional study.

Timeline

• Start date: 2026-05-01
• Primary completion: 2032-02-29
• Completion: 2032-02-29
• First posted: 2026-03-03
• Last updated: 2026-03-13